© 2003 by Oxford University Press
© 2003 Oxford University Press
REVIEW |
Pheochromocytoma: The Expanding Genetic Differential Diagnosis
Affiliations of authors: J. Bryant, J. Farmer, L. J. Kessler, K. L. Nathanson (Division of Medical Genetics), R. R. Townsend (Division of Nephrology), Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia.
Correspondence to: Katherine L. Nathanson, MD, 513 BRB 2/3, 421 Curie Blvd., University of Pennsylvania, Philadelphia, PA 19104 (e-mail: knathans{at}mail.med.upenn.edu).
Pheochromocytomas and paragangliomas are tumors of the autonomic nervous system; pheochromocytomas are tumors of the adrenal medulla, and paragangliomas are extra-adrenal tumors arising from either the sympathetic nervous system or parasympathetic ganglia. It has previously been estimated that approximately 10%–15% of pheochromocytomas are due to hereditary causes. However, our increased understanding of the three hereditary syndromes (neurofibromatosis 1, multiple endocrine neoplasia type 2, and von Hippel–Lindau syndrome) in which pheochromocytoma is found and the recent discovery that mutations in genes in the succinate dehydrogenase family (SDHB and SDHD) predispose to pheochromocytoma have necessitated a re-evaluation of the genetic basis of pheochromocytoma. These studies indicate that the frequency of germline mutations associated with isolated pheochromocytoma is higher than previously estimated, with both hospital-based series and a large population-based series indicating that the frequency of germline mutations in RET, VHL, SDHB, and SDHD taken together approximates 20%. In all patients with pheochromocytoma, including those with known hereditary syndrome or a positive family history, the frequency of germline mutations in these four genes together approaches 30%. Given the frequency of germline mutations, consideration should be given to genetic counseling for all patients with pheochromocytoma and is particularly important for individuals with a positive family history, multifocal disease, or a diagnosis before age 50. Identification of patients with hereditary pheochromocytoma is important because it can guide medical management in mutation-positive patients and their families. This review provides an overview of the known genetic syndromes that are commonly associated with pheochromocytoma, examines recent data on the association of germline mutations in the succinate dehydrogenase gene family with pheochromocytoma, and suggests guidelines for the genetic evaluation of pheochromocytoma patients.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  N B Kiss, J Geli, F Lundberg, C Avci, D Velazquez-Fernandez, J Hashemi, G Weber, A Hoog, T J Ekstrom, M Backdahl, et al. Methylation of the p16INK4A promoter is associated with malignant behavior in abdominal extra-adrenal paragangliomas but not pheochromocytomas Endocr. Relat. Cancer, June 1, 2008; 15(2): 609 - 621. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Korpershoek, B.-J. Petri, F. H van Nederveen, W. N M Dinjens, A. A Verhofstad, W. W de Herder, S. Schmid, A. Perren, P. Komminoth, and R. R de Krijger Candidate gene mutation analysis in bilateral adrenal pheochromocytoma and sympathetic paraganglioma Endocr. Relat. Cancer, June 1, 2007; 14(2): 453 - 462. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. M Brouwers, S. Glasker, A. F Nave, A. O Vortmeyer, I. Lubensky, S. Huang, M. S Abu-Asab, G. Eisenhofer, R. J Weil, D. M Park, et al. Proteomic profiling of von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 pheochromocytomas reveals different expression of chromogranin B Endocr. Relat. Cancer, June 1, 2007; 14(2): 463 - 471. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Kaji, J. A Carrasquillo, W M. Linehan, C. C Chen, G. Eisenhofer, P. A Pinto, E. W Lai, and K. Pacak The role of 6-[18F]fluorodopamine positron emission tomography in the localization of adrenal pheochromocytoma associated with von Hippel-Lindau syndrome Eur. J. Endocrinol., April 1, 2007; 156(4): 483 - 487. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. H. Pham, C. Moir, G. B. Thompson, A. E. Zarroug, C. E. Hamner, D. Farley, J. van Heerden, A. N. Lteif, and W. F. Young Jr Pheochromocytoma and Paraganglioma in Children: A Review of Medical and Surgical Management at a Tertiary Care Center Pediatrics, September 1, 2006; 118(3): 1109 - 1117. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. R BORNSTEIN and A.-P. GIMENEZ-ROQUEPLO Genetic testing in pheochromocytoma: increasing importance for clinical decision making. Ann. N.Y. Acad. Sci., August 1, 2006; 1073: 94 - 103. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E BENN, A. L. RICHARDSON, D. J MARSH, and B. G ROBINSON Genetic testing in pheochromocytoma- and paraganglioma-associated syndromes. Ann. N.Y. Acad. Sci., August 1, 2006; 1073: 104 - 111. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E KORPERSHOEK, F. H VAN NEDERVEEN, H DANNENBERG, B. J PETRI, P KOMMINOTH, A PERREN, J. W LENDERS, A. A VERHOFSTAD, W. W DE HERDER, R. R DE KRIJGER, et al. Genetic analyses of apparently sporadic pheochromocytomas: the rotterdam experience. Ann. N.Y. Acad. Sci., August 1, 2006; 1073: 138 - 148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. R DE KRIJGER, F. H VAN NEDERVEEN, E. KORPERSHOEK, W. W DE HERDER, S. M.P.F DE MUINCK KEIZER-SCHRAMA, and W. N.M DINJENS Frequent genetic changes in childhood pheochromocytomas. Ann. N.Y. Acad. Sci., August 1, 2006; 1073: 166 - 176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A.-L. TONG, Z.-P. ZENG, H.-Z. LI, D. YANG, L. LU, M. LI, Y.-R. ZHOU, J. ZHANG, S. CHEN, and W. LIANG Von Hippel-Lindau Gene Mutation in Non-Syndromic Familial Pheochromocytomas. Ann. N.Y. Acad. Sci., August 1, 2006; 1073: 203 - 207. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. L.M DAHIA and FOR THE FAMILIAL PHEOCHROMOCYTOMA CONSORTIUM Transcription Association of VHL and SDH Mutations Link Hypoxia and Oxidoreductase Signals in Pheochromocytomas. Ann. N.Y. Acad. Sci., August 1, 2006; 1073: 208 - 220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. AHLMAN Malignant pheochromocytoma: state of the field with future projections. Ann. N.Y. Acad. Sci., August 1, 2006; 1073: 449 - 464. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. WANGBERG, A. MUTH, A. KHORRAM-MANESH, S. JANSSON, O. NILSSON, E. FORSSELL-ARONSSON, L. TISELL, and H. AHLMAN Malignant pheochromocytoma in a population-based study: survival and clinical results. Ann. N.Y. Acad. Sci., August 1, 2006; 1073: 512 - 516. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S TISCHLER, N. KIMURA, and A. M. MCNICOL Pathology of Pheochromocytoma and Extra-adrenal Paraganglioma. Ann. N.Y. Acad. Sci., August 1, 2006; 1073: 557 - 570. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. GIMM, U. KRAUSE, M. BRAUCKHOFF, C. HOANG-VU, and H. DRALLE Distinct expression of galectin-3 in pheochromocytomas. Ann. N.Y. Acad. Sci., August 1, 2006; 1073: 571 - 577. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. W. B. de Groot, T. P. Links, J. T. M. Plukker, C. J. M. Lips, and R. M. W. Hofstra RET as a Diagnostic and Therapeutic Target in Sporadic and Hereditary Endocrine Tumors Endocr. Rev., August 1, 2006; 27(5): 535 - 560. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Amar, J. Bertherat, E. Baudin, C. Ajzenberg, B. Bressac-de Paillerets, O. Chabre, B. Chamontin, B. Delemer, S. Giraud, A. Murat, et al. Genetic Testing in Pheochromocytoma or Functional Paraganglioma J. Clin. Oncol., December 1, 2005; 23(34): 8812 - 8818. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. L.M. Dahia, K. Hao, J. Rogus, C. Colin, M. A.G. Pujana, K. Ross, D. Magoffin, N. Aronin, A. Cascon, C. Y. Hayashida, et al. Novel Pheochromocytoma Susceptibility Loci Identified by Integrative Genomics Cancer Res., November 1, 2005; 65(21): 9651 - 9658. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.-T. Huynh, K. Pacak, F. M Brouwers, M. S Abu-Asab, R. A Worrell, M. M Walther, A. G Elkahloun, D. S Goldstein, S. Cleary, and G. Eisenhofer Different expression of catecholamine transporters in phaeochromocytomas from patients with von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 Eur. J. Endocrinol., October 1, 2005; 153(4): 551 - 563. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. W. A. Vogel, F. M. Brouwers, I. A. Lubensky, A. O. Vortmeyer, R. J. Weil, M. M. Walther, E. H. Oldfield, W. M. Linehan, K. Pacak, and Z. Zhuang Differential Expression of Erythropoietin and Its Receptor in von Hippel-Lindau-Associated and Multiple Endocrine Neoplasia Type 2-Associated Pheochromocytomas J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3747 - 3751. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Garber and K. Offit Hereditary Cancer Predisposition Syndromes J. Clin. Oncol., January 10, 2005; 23(2): 276 - 292. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G Eisenhofer, T-T Huynh, K Pacak, F M Brouwers, M M Walther, W M Linehan, P J Munson, M Mannelli, D S Goldstein, and A G Elkahloun Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippel-Lindau syndrome Endocr. Relat. Cancer, December 1, 2004; 11(4): 897 - 911. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Eisenhofer, S. R Bornstein, F. M Brouwers, N.-K. V Cheung, P. L Dahia, R. R de Krijger, T. J Giordano, L. A Greene, D. S Goldstein, H. Lehnert, et al. Malignant pheochromocytoma: current status and initiatives for future progress Endocr. Relat. Cancer, September 1, 2004; 11(3): 423 - 436. [Abstract] [Full Text] [PDF]
|
|